Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Malaria

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial.

BMC medicine·2024

Same author

Baseline TGF-β correlates with protection after immunization with Plasmodium falciparum sporozoites in the controlled human malaria infection model.

Immunology letters·2023

Same author

[Development of vaccines against malaria; progress with contributions from the Netherlands].

Nederlands tijdschrift voor geneeskunde·2020

Same author

[Splenomegaly in an Eritrean refugee: the hyper-reactive malaria splenomegaly syndrome.]

Nederlands tijdschrift voor geneeskunde·2016

Same author

Malaria vaccines getting close to clinical reality.

Vaccine·2015

Same author

Transmission blocking malaria vaccines: Assays and candidates in clinical development.

Vaccine·2015

Same journal

Th1 recruitment in atopic dermatitis is due to suppression rather than amplification of Th2.

Immunology letters·2026

Same journal

Interleukin-6: A Potential Link in the Pathophysiology of Restless Legs Syndrome.

Immunology letters·2026

Same journal

The dendritic cell identity crisis: Why do conflicting classifications demand a consensus framework?

Immunology letters·2026

Same journal

The malignancy within: what cancer teaches us about human bonds.

Immunology letters·2026

Same journal

Progranulin enhances complement component 5a-primed neutrophil activation in antineutrophil cytoplasmic antibody-associated vasculitis.

Immunology letters·2026

Same journal

The newly identified role of TRIM72, an E3 ligase, in NINJ1-mediated plasma membrane rupture: focus on its anti-inflammatory function.

Immunology letters·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 26, 2026

Generating Genetically Modified Plasmodium berghei Sporozoites

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

Clinical malaria vaccine development.

R W Sauerwein¹

¹Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands. r.sauwerwein@mmb.umcn.nl

Immunology Letters

|December 23, 2008

Summary

This summary is machine-generated.

Malaria poses a significant global health threat, particularly in sub-Saharan Africa, causing millions of infections and deaths annually. Developing effective malaria vaccines is crucial due to increasing drug resistance and the high mortality rate, especially in young children.

More Related Videos

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Published on: May 18, 2016

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

Related Experiment Videos

Last Updated: Jun 26, 2026

Generating Genetically Modified Plasmodium berghei Sporozoites

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Published on: May 18, 2016

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

Area of Science:

Tropical medicine
Immunology
Vaccinology

Background:

Malaria remains a critical global health challenge, predominantly impacting sub-Saharan Africa.
Annual global infections range from 300 to 500 million, with 1 to 3 million fatalities, disproportionately affecting young children.
Rising Plasmodium falciparum resistance to existing antimalarial drugs necessitates alternative control strategies.

Purpose of the Study:

To highlight the urgent need for novel malaria vaccines.
To underscore the public health and economic burden of malaria.
To emphasize vaccination as a key strategy for disease reduction.

Main Methods:

This study is a review of current malaria challenges and vaccine development needs.
Analysis of global malaria epidemiological data.
Assessment of antimalarial drug resistance trends.

Main Results:

Malaria causes substantial economic and public health damage, especially in endemic regions.
Vaccination is a proven method for controlling infectious diseases.
Drug resistance compromises current malaria treatment efficacy.

Conclusions:

Development of effective malaria vaccines is imperative to combat the disease.
Vaccination strategies are essential for reducing malaria-related morbidity and mortality.
Urgent investment in malaria vaccine research and development is required.